Contingency Management Program to Treat Methamphetamine Use in Adults Hospitalized for Trauma in Hawaii

What this Trial Is About

Researchers are studying contingency management CM as a behavioral approach to address methamphetamine use among individuals in Hawaii who have been hospitalized due to traumatic injury. The study aims to gather data on the effectiveness of a pilot CM program and to understand participant perspectives on engaging with this intervention at a Level 1 Trauma Center. This research focuses on both patient-reported and biologically-confirmed outcomes over the medium term. Participants will attend follow-up clinics up to three times per week for up to 12 weeks after discharge to complete urinalysis tests. Those who test negative for methamphetamine receive positive reinforcement through a prize draw with various rewards ranging from praise to valuable items. The program includes Treatment Effectiveness Assessments at 6 and 12 weeks, along with a qualitative interview conducted at the end of the CM program. Throughout the study, participants will provide urine samples multiple times weekly and complete scheduled assessments to measure treatment effectiveness. The primary outcomes include the Treatment Effectiveness Assessment results at 6 and 12 weeks, and qualitative feedback is collected at the programs conclusion. The total participation period covers enrollment through 12 weeks post-discharge, with ongoing encouragement to continue engagement regardless of test results.

Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii